Manufacture of highly phosphorylated lysosomal enzymes and uses thereof

Details for Australian Patent Application No. 2005211775 (hide)

International Classifications

Event Publications

24 August 2006 PCT application entered the National Phase

PCT publication WO2005/077093 Priority application(s): WO2005/077093

8 October 2009 Application Accepted

Published as AU-B-2005211775

17 December 2009 Application for Amendment

The nature of the amendment is: Amend the name of the inventor to delete coinventor Kakkis, Emil D. and add co-inventor Starr, Chris. Address for service in Australia - Wrays Ground Floor 56 Ord Street West Perth WA 6005

8 April 2010 Amendment Made

The nature of the amendment is: Delete co-inventor Kakkis, Emil D. and add co-inventor Starr, Chris 2005222573 3M Innovative Properties Company The nature of the amendment is: Amend the invention title to read Unit dose delivery system for two-component composition

15 April 2010 Standard Patent Sealed

30 August 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.